Research programme: HIV prophylaxis vaccine - AdvaxisAlternative Names: Lovaxin H
Latest Information Update: 21 Feb 2011
At a glance
- Originator Advaxis
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 May 2009 Preclinical development is ongoing in the USA
- 30 May 2006 Preclinical trials in HIV infections prevention in USA (unspecified route)